US Biomax, Inc.

GL722a

Brain glioma and normal tissue array, including pathology grade, 24 cases/72 cores, replacing GL722

Microarray Panel:Brain glioma and normal tissue microarray, containing 11 cases of astrocytoma, 8 glioblastoma, 1 each of oligodendroglioma and malignant ependymoma, 3 normal tissue, triplicated cores per case
Cores:72
Cases:24
Layout:9 cols × 8 rows
Core Diameter:1.5 mm
Thickness:5 µm
Applications:

Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.

Notes:1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most of the TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). We still recommend 30 minutes of baking at 60°C before putting into xylene for de-paraffinization procedure.


Microarray Panel Display

 
Slide Label: US Biomax, Inc. Tissue Array
123456789 
A Cer Cer Cer Cer Cer Cer Cer Cer Cer  
B Cer Cer Cer Cer Cer Cer Cer Cer Cer  
C Cer Cer Cer Cer Cer Cer Cer Cer Cer  
D Cer Cer Cer Cer Cer Cer Cer Cer Cer  
E Cer Cer Cer Cer Cer Cer Cer Cer Cer  
F Cer Cer Cer Cer Cer Cer Cer Cer Cer  
G Cer Cer Cer Cer Cer Cer Cer Cer Cer  
H Cer Cer Cer Cer Cer Cer Cer Cer Cer Marked point
Legend: Cer - Cerebrum

- Malignant tumor, - Normal tissue

Specification Sheet

Pos No. Sex Age Organ Pathology diagnosis Grade Type †
A1 1 F 34 Cerebrum Astrocytoma 1–2 Malignant
A2 2 F 34 Cerebrum Astrocytoma 1–2 Malignant
A3 3 F 34 Cerebrum Astrocytoma 1–2 Malignant
A4 4 M 33 Cerebrum Astrocytoma 1–2 Malignant
A5 5 M 33 Cerebrum Astrocytoma Malignant
A6 6 M 33 Cerebrum Astrocytoma 1–2 Malignant
A7 7 M 25 Cerebrum Astrocytoma 1–2 Malignant
A8 8 M 25 Cerebrum Astrocytoma 2 Malignant
A9 9 M 25 Cerebrum Astrocytoma 2 Malignant
B1 10 F 40 Cerebrum Astrocytoma 1 Malignant
B2 11 F 40 Cerebrum Astrocytoma 1 Malignant
B3 12 F 40 Cerebrum Astrocytoma 1 Malignant
B4 13 M 41 Cerebrum Astrocytoma 2 Malignant
B5 14 M 41 Cerebrum Astrocytoma 2 Malignant
B6 15 M 41 Cerebrum Astrocytoma 2 Malignant
B7 16 M 35 Cerebrum Astrocytoma 2 Malignant
B8 17 M 35 Cerebrum Astrocytoma 2 Malignant
B9 18 M 35 Cerebrum Astrocytoma 2 Malignant
C1 19 M 37 Cerebrum Astrocytoma 2 Malignant
C2 20 M 37 Cerebrum Astrocytoma 2 Malignant
C3 21 M 37 Cerebrum Astrocytoma 2 Malignant
C4 22 M 49 Cerebrum Astrocytoma 3 Malignant
C5 23 M 49 Cerebrum Astrocytoma 2 Malignant
C6 24 M 49 Cerebrum Astrocytoma 3 Malignant
C7 25 M 62 Cerebrum Astrocytoma 2–3 Malignant
C8 26 M 62 Cerebrum Astrocytoma 2–3 Malignant
C9 27 M 62 Cerebrum Astrocytoma 2–3 Malignant
D1 28 M 53 Cerebrum Astrocytoma 2–3 Malignant
D2 29 M 53 Cerebrum Astrocytoma 2–3 Malignant
D3 30 M 53 Cerebrum Astrocytoma 2–3 Malignant
D4 31 M 79 Cerebrum Astrocytoma 3–4 Malignant
D5 32 M 79 Cerebrum Astrocytoma 3–4 Malignant
D6 33 M 79 Cerebrum Astrocytoma 3–4 Malignant
D7 34 M 45 Cerebrum Glioblastoma 4 Malignant
D8 35 M 45 Cerebrum Glioblastoma 4 Malignant
D9 36 M 45 Cerebrum Glioblastoma 4 Malignant
E1 37 F 48 Cerebrum Glioblastoma 4 Malignant
E2 38 F 48 Cerebrum Glioblastoma 4 Malignant
E3 39 F 48 Cerebrum Glioblastoma 4 Malignant
E4 40 M 53 Cerebrum Glioblastoma 4 Malignant
E5 41 M 53 Cerebrum Glioblastoma 4 Malignant
E6 42 M 53 Cerebrum Glioblastoma 4 Malignant
E7 43 F 31 Cerebrum Glioblastoma 4 Malignant
E8 44 F 31 Cerebrum Glioblastoma 4 Malignant
E9 45 F 31 Cerebrum Glioblastoma 4 Malignant
F1 46 F 61 Cerebrum Glioblastoma 4 Malignant
F2 47 F 61 Cerebrum Glioblastoma 4 Malignant
F3 48 F 61 Cerebrum Glioblastoma 4 Malignant
F4 49 F 33 Cerebrum Glioblastoma 4 Malignant
F5 50 F 33 Cerebrum Glioblastoma 4 Malignant
F6 51 F 33 Cerebrum Glioblastoma 4 Malignant
F7 52 M 34 Cerebrum Glioblastoma 4 Malignant
F8 53 M 34 Cerebrum Glioblastoma 4 Malignant
F9 54 M 34 Cerebrum Glioblastoma 4 Malignant
G1 55 F 22 Cerebrum Glioblastoma 4 Malignant
G2 56 F 22 Cerebrum Glioblastoma 4 Malignant
G3 57 F 22 Cerebrum Glioblastoma 4 Malignant
G4 58 F 30 Cerebrum Oligodendroglioma 2 Malignant
G5 59 F 30 Cerebrum Oligodendroglioma 2 Malignant
G6 60 F 30 Cerebrum Oligodendroglioma 2 Malignant
G7 61 M 51 Cerebrum Malignant ependymoma Malignant
G8 62 M 51 Cerebrum Malignant ependymoma Malignant
G9 63 M 51 Cerebrum Malignant ependymoma Malignant
H1 64 F 38 Cerebrum Cerebrum tissue Normal
H2 65 F 38 Cerebrum Cerebrum tissue Normal
H3 66 F 38 Cerebrum Cerebrum tissue Normal
H4 67 F 50 Cerebrum Cerebrum tissue Normal
H5 68 F 50 Cerebrum Cerebrum tissue Normal
H6 69 F 50 Cerebrum Cerebrum tissue Normal
H7 70 M 35 Cerebrum Cerebrum tissue Normal
H8 71 M 35 Cerebrum Cerebrum tissue Normal
H9 72 M 35 Cerebrum Cerebrum tissue Normal
M 42 Adrenal gland Pheochromocytoma (tissue marker) Malignant

† For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis


Find overlapping cases with this tissue array: